Skip to main content
. 2015 Jul 2;16(7):14951–14960. doi: 10.3390/ijms160714951

Figure 2.

Figure 2

Scaly erythematous plaques occurring on the lower extremity 6 months after initiation of interferon-β (IFN-β).